Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06965725 · ClinicalTrials.gov registry record
Paired-Ring Mitral Annuloplasty Ring Sizing Device
A clinical trial of Heart Valve Diseases, sponsored by Endeavor Health.
- Active
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT06965725: Active study of Heart Valve Diseases, sponsored by Endeavor Health.
NCT06965725 is a study of Heart Valve Diseases that is active but no longer recruiting, run by Endeavor Health. The registered enrollment target is 22 participants, below the 1,083-participant average among 13 other Heart Valve Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06965725, a study of Heart Valve Diseases, is active but no longer recruiting, sponsored by Endeavor Health.
- ACTIVE NOT RECRUITING
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate a novel paired-ring mitral annuloplasty sizing system in humans.
Primary Outcome
Direct measurement of mitral leaflet coaptation length performed with the sizer in position, performed in mm using surgical (disposable) ruler.
Conditions Studied
Interventions
- DEVICE Annuloplasy ring sizing device
Study Locations (1)
Illinois
- Endeavor Health - Glenview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2025-07-03 |
| Est. Completion | 2026-11 |
What the registry record for NCT06965725 still lists
NCT06965725 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,083-participant average among 13 other Heart Valve Diseases trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Heart Valve Diseases appearing as the primary indexed condition, and to 1 intervention - of which Annuloplasy ring sizing device is the first listed.
NCT06965725 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06965725 about?
NCT06965725 is a clinical study titled "Paired-Ring Mitral Annuloplasty Ring Sizing Device". The purpose of this study is to evaluate a novel paired-ring mitral annuloplasty sizing system in humans.
What is the current status of trial NCT06965725?
This trial is currently active not recruiting. The enrollment target is 22 participants. The study started on 2025-07-03. Estimated completion is 2026-11.
What conditions does trial NCT06965725 study?
This clinical trial studies the following conditions: Heart Valve Diseases.
What interventions are being tested in trial NCT06965725?
The interventions under investigation include: Annuloplasy ring sizing device (DEVICE).
Who is sponsoring clinical trial NCT06965725?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06965725 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Valve Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06965725's enrollment target sits among peer trials
22 11th of 13 higher than 3 of 13 other Heart Valve Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Valve Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
The TRICURE EFS Study
RECRUITING · NA
-
Warfarin Patient Self-management Implementation in the US Healthcare System
RECRUITING · NA
-
Transpacific TAVR Registry
RECRUITING
-
EFS of the DUO System for Tricuspid Regurgitation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI